ABSTRACT Breathlessness was measured in 20 patients with severe chronic obstructive lung disease by the use of a visual-analogue scale. Severe resting arterial hypoxaemia was not a feature. The severity of breathlessness measured in this way did not correlate well with the results of spirometric tests or with walking ability. The use of portable oxygen was studied during simple walking tests for its effect on walking ability and the sensation of breathlessness. Portable oxygen improved exercise capacity but a placebo effect of the system probably accounted for some of the improvement. A clear improvement of distressing breathlessness was observed and represented a useful therapeutic response. Breathlessness and simple exercise ability were shown to respond independently to oxygen breathing. The value of short-term intermittent oxygen in patients with severe chronic obstructive lung disease needs to be evaluated in terms of both exercise ability and breathlessness.
The most frequent complaint of patients with chronic obstructive lung disease is breathlessness. Other symptoms of the disease are largely ignored until breathlessness begins to limit exercise capacity. Breathlessness as assessed by grades used by the Medical Research Council questionnaire on respiratory symptoms' increases as the spirometric measurements of airways obstruction decrease but the relationship is subject to large variability. For example, a common clinical observation is that one patient with a forced expiratory volume (FEVy) of 1 litre will profess such severe disability as to be housebound and yet another with identical functional values will be able to walk to work, albeit at a limited pace, and manage a light job. A questionnaire on breathlessness similar to that of Fletcher' was completed. Patients were asked to grade their breathlessness by placing a cross on a 100 mm line. The line was printed in the centre of a sheet of paper with the words "None" at the lefthand side and "Severe" at the right-hand side. An instruction requesting a cross to be placed between the limits according to how severe they considered their breathlessness to be was also printed on /min through the same apparatus. The patient was informed that he was breathing 3 I/min of oxygen during the latter air-breathing spell. The ambient air breathing test was included in the randomisation procedure. The apparatus weighed around 2 kg (between 4 and 5 lb) loaded for these tests, the Portagen system being used, and it was carried by the patient. At least half an hour's rest was allowed between walks. All walks were conducted by one of us (JW) walking behind the patient, who was allowed to set his own pace and stops. The distance walked was recorded. No interference of any sort was allowed during the walk but in 10 patients the pulse rate and respiratory rate were recorded within one minute of completion. A visual-analogue scale of effort required was completed within one minute of the walk. The patient was asked how difficult he had found it. The same procedure was followed as for the visual-analogue scale for breathlessness except that the instructions now contained the word "effort." The limit words on the 100 mm line were the same. It was realised that although breathlessness would be a major component of the effort this would also include symptoms such as general fatigue and muscle aching as these are the symptoms that terminate formal exercise tests such as bicycle ergometry in such patients.
After an interval of three weeks to three months patients were asked to repeat the tests. The order of performing the four walks was changed on the second occasion but the tests were otherwise identical. Student's t test for paired data was used to make statistical analysis. All patients gave informed consent to the tests.
Results
The 20 patients studied had a mean age of 61*2 ± 11*9 years. Table 1 shows details of their respiratory function. All had severe breathlessness at rest and advanced airways obstruction.
The figure relates the measurements of breathlessness calculated in millimetres from the zero point on the visual-analogue scale (VAB) to the FEV, made at the initial assessment. Despite a mean value of only 0.92 litres for FEV, values of VAB cover the full length of the scale (for VAB against FEV, r = 0-103). This accords with the clinical observation that some patients with advanced airways obstruction do not appear to be unduly disturbed by breathlessness yet others seem severely attract patients who feel they have dyspnoea. The poor relationship between the effort of walking and distance achieved reflects the same property. The factors which control distance or maximum exercise capacity under defined circumstances differ from sensations evolved during their performance. It is important to appreciate this difference as it may be possible to improve the nature of evolved sensation without changing exercise performance. Most of our patients did not have severe blood gas disturbance. It has always been debatable as to whether such patients with obstructive lung disease benefit from portable oxygen during walking. Portable oxygen was first considered of value in 1956 by Cotes and Gilson.6 Breathing 4 /min doubled walking distance on a treadmill; no control subjects were investigated. Pierce et a17 found that both training and exercise programmes were less stressful in physiological terms when supplementary oxygen was used. The first attempt at a controlled study was made by Bradley et al. 8 Patients with chronic airways obstruction exercised while breathing air, oxygen, and compressed air. No improvement of exercise capacity was observed between air, oxygen and compressed air breathing. Portable liquid air and oxygen breathing was compared in nine patients in a crossover study during walking by Lilker et al. 9 All patients said that they felt better using the portable apparatus but only three had improved exercise capacity during oxygen breathing. The first attempt to measure breathlessness independently of exercise performance in bronchitis was made by Woodcock et al.'0 Breathlessness was measured with a visualanalogue scale and exercise capacity assessed during a six-minute hospital corridor walk and by progressive exercise on a treadmill. Compressed air and oxygen were administered in double-blind fashion. Oxygen reduced breathlessness scores during exercise and slightly increased the distance walked in the hospital corridor and on the treadmill.
In our study the improvement in breathlessness during oxygen walking was substantial. The placebo test, although producing an improvement that was not quite statistically significant, gave a mean value equal to half the improvement. If more patients were studied probably placebo effects would be shown to account for at least half of the observed response. The difference in results between flow rates of 2 and 4 1/min was trivial. Improvement was associated with a relative fall of respiratory rate.
Resting respiratory rates were higher than in normal people but would be considered reasonable for this type of disabled patient. During oxygen breathing the respiratory rate hardly changed during exercise, in contrast to the further increase seen during air breathing. As exercise times were short the observed changes of respiratory rate might have been due to reflex effects.
The inappropriate awareness of breathing that constitutes breathlessness has been studied in terms of altered control of respiration,"'-" disturbed recognition of the detection of added resistive and elastic loads,'5-17 inappropriate pulmonary afferent receptor firing,18-20 and disturbed proprioception from the chest wall and abdomen.21-23 The sensation of breathlessness which allows one patient with bronchitis to be only trivially disturbed by his feelings and another with identical functional disturbance to profess severe disability is probably due to a central assimilation of such physiological information with the psychological factors that make up personality.
The visual-analogue scale measures this combined effect and should be capable of testing benefit when breathlessness is subjected to independent therapeutic intervention. Burns and Howell,2 in their study of disproportionately severe breathlessness in chronic bronchitis with depression, anxiety and hysterical reactions, found that treatment of the psychiatric disturbance improved breathlessness. Later Mitchell-Heggs et al3 using diazepam improved breathlessness in four patients described as "pink puffers," but the soporific effect has precluded more general use. Morphine and its derivatives have long been known to alleviate breathlessness in pulmonary oedema and bronchial asthma but its central respiratory depressant effect has made it unsuitable for use in bronchial asthma and chronic airways obstruction.
In summary, breathlessness can be measured as a sensation independent of airway function and exercise capacity by the use of the visual-analogue scale in chronic obstructive lung disease. Severe breathlessness may be treatable without necessarily improving airway function or exercise capacity in patients with heightened sensory awareness of breathlessness. Portable oxygen increases the distance walked and reduces breathlessness. The latter effect would seem to be the more important but much further work is needed to discover mechanisms and to select the patients most likely to benefit. 
